The value of waiting: Russia's integration into the international capital markets
Article Abstract:
Russia joined the international capital markets but foreign direct investments have been scarce and portfolio capitals are coming in temporarily. A study reveals that unclear macroeconomic stabilization affects the number of capital inflows negatively in irreversible investment decisions. However, lessening the uncertainty may bring more investments if the level of irreversibility is not lowered by institutional changes.
Publication Name: Journal of Comparative Economics
Subject: Economics
ISSN: 0147-5967
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Foreign direct investment in Central and Eastern European countries: a dynamic panel analysis
Article Abstract:
The dynamic panel data methods are used to study the determinants of foreign direct investment (FDI) into Central and Eastern European countries (CEECs). The empirical model shows that the traditional determinants such as market potential, low relative unit labor costs, a skilled workforce and relative endowments, have significant and plausible effects.
Publication Name: Journal of Comparative Economics
Subject: Economics
ISSN: 0147-5967
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Effective patent life of drugs in Sweden - a comparison with international studies. Rx Roulette: combatting counterfeit pharmaceuticals in developing nations
- Abstracts: Business cycles with distorting taxes and disaggregated capital markets. Ex post heterogeneity and the business cycle
- Abstracts: The trouble with stock options. Transportation costs and international trade in the second era of globalization
- Abstracts: The illusory effects of saving incentives on saving. Data watch: tort-uring the data. Policy watch: the expanding reach of the individual alternative minimum tax
- Abstracts: The relative importance of actual and potential competition: empirical evidence from the pharmaceuticals market